Stanford-Born Medical Company Advances Next Generation of Cancer Treatment Toward Clinical Deployment

SILICON VALLEY, Calif., July 9, 2026 /PRNewswire/ -- TibaRay, a Silicon Valley medical technology company founded on Stanford University research, announced today that its first Galactica™ cancer treatment systems have entered manufacturing. The milestone marks a major step for TibaRay as...

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.